Chief Medical Officer
Dr. Lang has over 20 years of experience in clinical development, leading programs from IND submission through to successful NDA approval in a variety of therapeutic areas in both big and small pharmaceutical companies.
Dr. Lang is trained as an Anesthesiologist and Pain Management Specialist. Prior to joining Nevakar in 2018 he held roles with increasing responsibility at Johnson and Johnson, Novartis, Javelin Pharmaceuticals (later acquired by Hospira), Grunenthal USA, Covance and EnteraBio.
Dr. Lang has a MD from Ben Gurion University in Israel with post graduate training from Emory University in Atlanta, GA. He is licensed in the US and Israel.